Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723752 | SCV000331502 | uncertain significance | not provided | 2015-08-27 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000295629 | SCV000538318 | likely benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 0.7% (116/16506) South Asian chromosomes |
Labcorp Genetics |
RCV001837821 | SCV000659280 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000578081 | SCV000679805 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000577967 | SCV000679806 | uncertain significance | Familial hypobetalipoproteinemia 1 | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000583315 | SCV000687231 | likely benign | Hypercholesterolemia, familial, 1 | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723752 | SCV000730570 | likely benign | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 14732481, 28008009, 26332594, 21408211, 27153395, 20981092, 30782561, 31150472, 26582918) |
Robarts Research Institute, |
RCV000583315 | SCV000782840 | likely benign | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000845396 | SCV000987460 | likely benign | Primary familial dilated cardiomyopathy | criteria provided, single submitter | clinical testing | ||
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000723752 | SCV001133405 | benign | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000583315 | SCV001135625 | benign | Hypercholesterolemia, familial, 1 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000723752 | SCV001152158 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | APOB: BP4 |
Illumina Laboratory Services, |
RCV000578081 | SCV001297957 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B | 2018-05-18 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Broad Center for Mendelian Genomics, |
RCV000578081 | SCV001422586 | likely benign | Hypercholesterolemia, autosomal dominant, type B | 2020-01-22 | criteria provided, single submitter | curation | The p.Arg1128His variant in APOB has been reported in 2 Caucasian individuals suspected to have familial hypercholesterolemia (DOI: 10.1016/S0735-1097(18)32309-X), and has been identified in 0.7219% (221/30614) of South Asian chromosomes, including 6 homozygotes, 0.4949% (639/129122) of European (non-Finnish) chromosomes, including 3 homozygotes, and 0.3753% (133/35438) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs12713843). This variant has also been reported in ClinVar as a VUS, likely benign, and benign variant (Variation ID: 281142). Computational prediction tools, including splice predictors, and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely benign. ACMG/AMP Criteria applied: BS1, BP4 (Richards 2015). |
Ambry Genetics | RCV002450797 | SCV002618278 | likely benign | Cardiovascular phenotype | 2018-10-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004529460 | SCV004103508 | uncertain significance | APOB-related disorder | 2023-02-13 | criteria provided, single submitter | clinical testing | The APOB c.3383G>A variant is predicted to result in the amino acid substitution p.Arg1128His. This variant has been reported as a variant of uncertain significance in an individual with primary hypocholesterolemia (Blanco-Vaca et al. 2019. PubMed ID: 30782561). In addition, this variant has been identified in three individuals with low lipid levels (Neale et al. 2011. PubMed ID: 21408211). This variant is reported in 0.72% of alleles in individuals of South Asian descent, and in nine homozygotes in gnomAD (http://gnomad.broadinstitute.org/variant/2-21238367-C-T), which suggests that it may be too common to be a primary cause of disease. This variant has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from benign to likely benign, to uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/281142/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
ARUP Laboratories, |
RCV000723752 | SCV004562152 | likely benign | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing | |
GENin |
RCV004584654 | SCV005074063 | benign | Familial hypercholesterolemia | 2022-09-26 | criteria provided, single submitter | clinical testing |